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Aim: Aim of the study was to compare angiographic and clinical outcomes after percutaneous coro-
nary interventions (PCI) using drug coated balloons (DCB) between patients treated for “de novo” le-
sions and in-stent restenosis (ISR) in acute coronary syndrome (ACS). 
Patients and Methods: Study included 128 ASC patients treated with DCB between 2012 and 2019. All 
coronary angiographies were reviewed to determine indication, lesion complexity, vessel size and pro-
cedural success. Baseline and follow up clinical data were extracted from hospital digital database. 
DES/DEB 
Extended Abstract 
TABlE 1. differences in clinical, angiographic and procedural characteristics between groups.  
ISR (N=24) Non-ISR (N=104) P value
Clinical characteristics
Patient age 68.36±6.85 62.85±11.37 0.002
Family history 7 (29.2) 44 (42.3) 0.23
Active smokers 3 (12.5) 40 (38.5) 0.015
Diabetes mellitus 7 (29.2) 35 (33.7) 0.67
Arterial hypertension 21 (87.5) 90 (86.5) 0.90
Hyperlipidaemia 21 (87.5) 88 (84.6) 0.72
Previous myocardial infarction 20 (83.3) 16 (15.4)  < 0.001
Atrial fibrillation 3 (12.5) 6 (5.8) 0.24
Ejection fraction 51.4±21.1 54.3±18.2 0.33
Angiographic and procedural characteristics
Vascular access - femoral 6 (25) 36 (34.6) 0.36
Multivessel disease 6 (25) 59 (56.7) 0.005
Bifurcation 5 (20.8) 45 (43.3) 0.042
Number of used DCB 1.0±0 1.1±0.3 0.004
Length (mm) 23.38±3.23 21.24±5.24 0.012
Diameter (mm) 2.85±0.59 2.48±0.49 0.007
Bail out PCI 0 8 (7.7) 0.16
Concomitant PCI 8 (33.3) 79 (75.9) <0.001
Total number of stents per person 0.5 1.2 0.002
Results are presented as mean ± standard deviation or absolute number (%).
ISR = in-stent restenosis; DCB = drug coated balloons; PCI = percutaneous coronary intervention.
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TABlE 2. comparison of clinical and angiographic outcomes between groups.
Results: Mean patient age was 63.8 years, with the majority being men (75.8%, N=97). In total, 24 (18.8%) patients were treated for 
ISR. Comparison of clinical, angiographic and procedural characteristics between groups is presented in Table 1. Patients in the 
non-ISR group had more often multivessel disease (56.7 vs 25.0%, p=0.005), bifurcation PCI (45.0 vs 20.8%, p=0.042) and more DCB 
used in the index event (1.1±0.3 vs 1.0±0, p=0.004). Furthermore, they had more concomitant PCI with stent implantation in other 
lesions (75.9 vs 33.3%, p<0.001) with consequent higher number of stents implanted per person (1.2 vs 0.5, p=0.002). Both mean 
DCB diameter and length were larger in the ISR group (2.85±0.59 mm vs 2.48±0.49 mm, p=0.007 and 23.38±3.23 vs 21.24±5.24 mm, 
p=0.012, respectively). In the non-ISR group 8 (7.7%) patients had “bail out” stent implantation, while none was done in ISR group. 
Mean angiographic and clinical follow up was not significantly different between groups (Table 2). Altogether 75 (58.6%) patients 
underwent repeated coronary angiography, more often in the non-ISR group (64.4% vs 33.3%, p=0.005) but most of those were elec-
tive (73.1%). There was no significant difference in the composite endpoint consisted of death, unplanned rehospitalisation, target 
vessel revascularization and target lesion failure (ISR vs non-ISR; 29.2% vs 26.9%, p=0.82), nor in any of its components (Table 2). 
ISR (N=24) Non-ISR (N=104) P value
Angiographic follow up (years) 1.59±1.45 0.87±1.38 0.22
Clinical follow up (years) 2.51±2.02 2.52±2.36 0.98
Repeated coronarography 8 (33.3) 67 (64.4) 0.005
Elective 6 (25) 85 (55.8) 0.006
Target lesion failure 4 (16.7) 9 (8.6) 0.32
Target vessel revascularization 2 (8.3) 7 (6.7) 0.78
Unplanned hospitalization 6 (25) 18 (17.3) 0.38
Death 1 (4.2) 5 (4.8) 0.89
Results are presented as mean ± standard deviation or absolute number (%).
ISR=in-stent restenosis.
Conclusions: DCB in treatment of native coronary arteries provides similar angiographic and clinical outcomes compared to DCB 
for ISR in patients presenting with ACS in real-world settings.1 Furthermore, the prevalence of target lesion failure after DCB treat-
ment was smaller in native coronary arteries compared to ISR. 
